Your browser doesn't support javascript.
loading
Genetic Mosaicism in Calmodulinopathy.
Wren, Lisa M; Jiménez-Jáimez, Juan; Al-Ghamdi, Saleh; Al-Aama, Jumana Y; Bdeir, Amnah; Al-Hassnan, Zuhair N; Kuan, Jyn L; Foo, Roger Y; Potet, Franck; Johnson, Christopher N; Aziz, Miriam C; Carvill, Gemma L; Kaski, Juan-Pablo; Crotti, Lia; Perin, Francesca; Monserrat, Lorenzo; Burridge, Paul W; Schwartz, Peter J; Chazin, Walter J; Bhuiyan, Zahurul A; George, Alfred L.
Afiliación
  • Wren LM; From the Department of Pharmacology (L.M.W., F.P., P.W.B., A.L.G.), Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Jiménez-Jáimez J; Cardiology Department (J.J.-J.), Virgen de las Nieves Hospital, Granada, Spain.
  • Al-Ghamdi S; Cardiac Sciences Department, Section of Pediatric Cardiology, King Abdulaziz Cardiac Center, Ministry of National Guard Health Affairs, Riyadh (S.A.-G.).
  • Al-Aama JY; Department of Genetic Medicine, Faculty of Medicine (J.Y.A.-A.), King Abdulaziz University, Jeddah.
  • Bdeir A; Princess Al Jawhara Albrahim Center of Excellence in Research of Hereditary Disorders (J.Y.A.-A., A.B.), King Abdulaziz University, Jeddah.
  • Al-Hassnan ZN; Princess Al Jawhara Albrahim Center of Excellence in Research of Hereditary Disorders (J.Y.A.-A., A.B.), King Abdulaziz University, Jeddah.
  • Kuan JL; The Cardiovascular Genetics Program, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (Z.N.A.-H.).
  • Foo RY; Department of Cardiology, National University Heart Center and Cardiovascular Research Institute, National University of Singapore (J.L.K., R.Y.F.).
  • Potet F; Department of Cardiology, National University Heart Center and Cardiovascular Research Institute, National University of Singapore (J.L.K., R.Y.F.).
  • Johnson CN; From the Department of Pharmacology (L.M.W., F.P., P.W.B., A.L.G.), Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Aziz MC; Department of Biochemistry and Center for Structural Biology, Vanderbilt University, Nashville, TN (C.N.J., W.J.C.).
  • Carvill GL; Department of Neurology (M.C.A., G.L.C.), Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Kaski JP; Department of Neurology (M.C.A., G.L.C.), Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Crotti L; Institute of Cardiovascular Science, University College London, United Kingdom (J.-P.K.).
  • Perin F; Department of Medicine and Surgery, University of Milano-Bicocca (L.C.).
  • Monserrat L; IRCCS Istituto Auxologico Italiano, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy (L.C., P.J.S.).
  • Burridge PW; Cardiology Department, Health in Code SL, A Coruña, Spain (L.M.).
  • Schwartz PJ; Pediatric Cardiology Division (F.P.), Virgen de las Nieves Hospital, Granada, Spain.
  • Chazin WJ; Cardiology Department, Health in Code SL, A Coruña, Spain (L.M.).
  • Bhuiyan ZA; From the Department of Pharmacology (L.M.W., F.P., P.W.B., A.L.G.), Northwestern University Feinberg School of Medicine, Chicago, IL.
  • George AL; IRCCS Istituto Auxologico Italiano, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy (L.C., P.J.S.).
Circ Genom Precis Med ; 12(9): 375-385, 2019 09.
Article en En | MEDLINE | ID: mdl-31454269
ABSTRACT

BACKGROUND:

CaM (calmodulin) mutations are associated with congenital arrhythmia susceptibility (calmodulinopathy) and are most often de novo. In this report, we sought to broaden the genotype-phenotype spectrum of calmodulinopathies with 2 novel calmodulin mutations and to investigate mosaicism in 2 affected families.

METHODS:

CaM mutations were identified in 4 independent cases by DNA sequencing. Biochemical and electrophysiological studies were performed to determine functional consequences of each mutation.

RESULTS:

Genetic studies identified 2 novel CaM variants (CALM3-E141K in 2 cases; CALM1-E141V) and one previously reported CaM pathogenic variant (CALM3-D130G) among 4 probands with shared clinical features of prolonged QTc interval (range 505-725 ms) and documented ventricular arrhythmia. A fatal outcome occurred for 2 of the cases. The parents of all probands were asymptomatic with normal QTc duration. However, 2 of the families had multiple affected offspring or multiple occurrences of intrauterine fetal demise. The mother from the family with recurrent intrauterine fetal demise exhibited the CALM3-E141K mutant allele in 25% of next-generation sequencing reads indicating somatic mosaicism, whereas CALM3-D130G was present in 6% of captured molecules of the paternal DNA sample, also indicating mosaicism. Two novel mutations (E141K and E141V) impaired Ca2+ binding affinity to the C-domain of CaM. Human-induced pluripotent stem cell-derived cardiomyocytes overexpressing mutant or wild-type CaM showed that both mutants impaired Ca2+-dependent inactivation of L-type Ca2+ channels and prolonged action potential duration.

CONCLUSIONS:

We report 2 families with somatic mosaicism associated with arrhythmogenic calmodulinopathy, and demonstrate dysregulation of L-type Ca2+ channels by 2 novel CaM mutations affecting the same residue. Parental mosaicism should be suspected in families with unexplained fetal arrhythmia or fetal demise combined with a documented CaM mutation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arritmias Cardíacas / Calmodulina / Mosaicismo Tipo de estudio: Prognostic_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Circ Genom Precis Med Año: 2019 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arritmias Cardíacas / Calmodulina / Mosaicismo Tipo de estudio: Prognostic_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: Circ Genom Precis Med Año: 2019 Tipo del documento: Article País de afiliación: Israel
...